Background:
- Thymic epithelial tumors (TETs), which include thymomas (TMM) and thymic carcinomas (TC), are rare, yet they are the most common neoplasms in the anterior mediastinum.
- TETs can lead to significant morbidity and mortality.
- Thymomas are categorized into subtypes based on histological features (WHO subtypes – A, AB, B1, B2, B3)
- To develop more effective therapeutics for TETs, it is necessary to better understand their molecular underpinnings.
- Herein, we present the findings from an in-depth molecular characterization of TETs.